Patents by Inventor Patrick C. Wilson

Patrick C. Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250047925
    Abstract: Assets of broadcast network content are targeted to network users of interest based on location information regarding user equipment devices. Asset providers can specify location targeting criteria via a graphical user interface displaying mapping information. This location targeting criteria can then be compared to location information regarding user equipment devices so that assets are delivered to appropriate devices. The comparison of the location targeting criteria to the device location information can be performed at the user equipment devices or at another location. In the latter case, the assets can be addressed to appropriate user equipment devices or appropriate user equipment devices can be directed to select the asset, which is broadcast via the network. In this manner, assets can be targeted to individual network users on a basis independent of network topology.
    Type: Application
    Filed: March 12, 2024
    Publication date: February 6, 2025
    Inventors: Patrick M. Sheehan, Bruce J. Anderson, Daniel C. Wilson
  • Patent number: 10357563
    Abstract: Provided herein are compositions useful for neutralization of influenza virus, and methods of use and manufacture thereof. In particular, compositions comprising antibodies that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: July 23, 2019
    Assignee: The University of Chicago
    Inventors: Patrick C. Wilson, Carole J. Henry Dunand
  • Patent number: 10208107
    Abstract: Antibodies that specifically bind influenza virus hemagglutinin A (HA), and antigen binding fragments thereof are disclosed herein. In several embodiments, these antibodies are broadly neutralizing. Nucleic acids encoding these monoclonal antibodies, vectors including these nucleic acids, and host cells transformed with these vectors are also disclosed. Compositions are disclosed that include these antibodies, antigen binding fragments, nucleic acids, vectors and host cells. Method of using these antibodies, and antigen binding fragments, nucleic acids, vectors and host cells, such as for diagnosis and treatment of an influenza virus infection are also provided.
    Type: Grant
    Filed: March 29, 2016
    Date of Patent: February 19, 2019
    Assignees: Emory University, The University of Chicago
    Inventors: Rafi Ahmed, Jens Wrammert, Patrick C. Wilson
  • Publication number: 20170360931
    Abstract: Provided herein are compositions useful for neutralization of influenza virus, and methods of use and manufacture thereof. In particular, compositions comprising antibodies that are cross-reactive with multiple influenza strains are provided, as well as methods of treatment and prevention of influenza infection therewith.
    Type: Application
    Filed: December 17, 2015
    Publication date: December 21, 2017
    Inventors: Patrick C. WILSON, Carole J. Henry DUNAND
  • Patent number: 9469685
    Abstract: Antibodies or antibody fragments, wherein the antibody or the fragment binds HA domain of influenza virus (e.g. H1N1, H5N1, or both). Also described are cloned human antibodies that bind influenza.
    Type: Grant
    Filed: January 10, 2012
    Date of Patent: October 18, 2016
    Assignees: Emory University, The University of Chicago
    Inventors: Rafi Ahmed, Jens Wrammert, Patrick C. Wilson
  • Publication number: 20160200800
    Abstract: Antibodies that specifically bind influenza virus hemagglutinin A (HA), and antigen binding fragments thereof are disclosed herein. In several embodiments, these antibodies are broadly neutralizing. Nucleic acids encoding these monoclonal antibodies, vectors including these nucleic acids, and host cells transformed with these vectors are also disclosed. Compositions are disclosed that include these antibodies, antigen binding fragments, nucleic acids, vectors and host cells. Method of using these antibodies, and antigen binding fragments, nucleic acids, vectors and host cells, such as for diagnosis and treatment of an influenza virus infection are also provided.
    Type: Application
    Filed: March 29, 2016
    Publication date: July 14, 2016
    Inventors: Rafi Ahmed, Jens Wrammert, Patrick C. Wilson
  • Patent number: 9321829
    Abstract: Antibodies that specifically bind influenza virus hemagglutinin A (HA), and antigen binding fragments thereof are disclosed herein. In several embodiments, these antibodies are broadly neutralizing. Nucleic acids encoding these monoclonal antibodies, vectors including these nucleic acids, and host cells transformed with these vectors are also disclosed. Compositions are disclosed that include these antibodies, antigen binding fragments, nucleic acids, vectors and host cells. Method of using these antibodies, and antigen binding fragments, nucleic acids, vectors and host cells, such as for diagnosis and treatment of an influenza virus infection are also provided.
    Type: Grant
    Filed: October 18, 2012
    Date of Patent: April 26, 2016
    Assignee: Emory University
    Inventors: Rafi Ahmed, Jens Wrammert, Patrick C. Wilson
  • Publication number: 20140348851
    Abstract: Antibodies that specifically bind influenza virus hemagglutinin A (HA), and antigen binding fragments thereof are disclosed herein. In several embodiments, these antibodies are broadly neutralizing. Nucleic acids encoding these monoclonal antibodies, vectors including these nucleic acids, and host cells transformed with these vectors are also disclosed. Compositions are disclosed that include these antibodies, antigen binding fragments, nucleic acids, vectors and host cells. Method of using these antibodies, and antigen binding fragments, nucleic acids, vectors and host cells, such as for diagnosis and treatment of an influenza virus infection are also provided.
    Type: Application
    Filed: October 18, 2012
    Publication date: November 27, 2014
    Applicants: THE UNIVERSITY OF CHICAGO, EMORY UNIVERSITY
    Inventors: Rafi Ahmed, Jens Wrammert, Patrick C. Wilson
  • Publication number: 20140046039
    Abstract: Antibodies or antibody fragments, wherein the antibody or the fragment binds HA domain of influenza virus (e.g. H1N1, H5N1, or both).
    Type: Application
    Filed: January 10, 2012
    Publication date: February 13, 2014
    Applicants: THE UNIVERSITY OF CHICAGO, EMORY UNIVERSITY
    Inventors: Rafi Ahmed, Jens Wrammert, Patrick C. Wilson
  • Patent number: 8563305
    Abstract: High efficient methods for producing an antibody molecule that binds an antigen are described. The methods include obtaining a population of PBMC enriched for CD19highCD3negCD20low to negCD38highCD27high cells from a mammal exposed to an antigen from sample of cells enriched for PBMC. The cells are isolated from a sample obtained at a time that the fraction of PBMC expressing antibody reactive to the antigen is at a high level. Sequences encoding heavy and light chain variable domains are prepared in a manner that allow production of molecules with natural heavy and light chain pairing.
    Type: Grant
    Filed: April 30, 2009
    Date of Patent: October 22, 2013
    Assignees: Oklahoma Medical Research Foundation, Emory University
    Inventors: Rafi Ahmed, Joseph Miller, Patrick C. Wilson, J. Donald Capra, Jens Wrammert